Hydroxychloroquine Sulfate

• A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active convent… Pending
  2024-516723-14-00 Phase IV 4 countries Karolinska Institutet
• Hydroxychloroquine in progressive MS Pending
  2025-522573-11-00 Phase II 1 country Varsinais-Suomen hyvinvointialue
• The OASE study Pending
  2026-525221-21-01 Phase IV 1 country Aalborg University Hospital
• C0251006 - A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-06823859 IN … Recruiting
  2022-502739-20-00 Phase III 10 countries Pfizer Inc.
• Therapeutic effect of Hydroxychloroquine on IgA Nephropathy course - QUIgAN Study Recruiting
  2024-512653-25-00 Phase III 1 country Centre Hospitalier Universitaire De Saint Etienne
• “The BAPTIST study” Baricitinib in calcium pyrophosphAte dePosiTion dIseaSe Trial – a proof of concept phase II clinical trial . Recruiting
  2024-511864-95-00 Phase II 1 country Ospedale Galeazzi S.p.A.
• QUIDOSE. Randomized controlled trial testing the efficacy of hydroxychloroquine combined with low dose corticosteroid therapy in pulmonary s… Recruiting
  2024-516101-23-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• HydroxyChloroquine as steroid-sparing Agent in Extra-pulmonary SARcoidosis. A multicenter, prospective, placebo-controlled, randomized trial… Recruiting
  2022-502155-65-00 Phase III 1 country Hospices Civils De Lyon
• A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic inflammat… Recruiting
  2022-502851-79-00 Phase III 19 countries Argenx
• HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibod… Recruiting
  2023-504661-23-00 Phase III 3 countries Rigshospitalet
• Hydroxychloroquine in isolated cutaneous mastocytosis patients or indolent systemic mastocytosis with associated skin involvement patients: … Recruiting
  2024-518594-33-00 Phase III 1 country Centre Hospitalier Universitaire De Toulouse
• Hydroxychloroquine treatment for Recurrent Pregnancy Loss: a randomized double-blind placebo-controlled trial Recruiting
  2024-515579-36-00 Phase II 1 country Hvidovre Hospital
• RANDOMIZED CONTROLLED CLINICAL TRIAL EVALUATING METHOTREXATE OR LEFLUNOMIDE + TARGETED THERAPY VERSUS METHOTREXATE OR LEFLUNOMIDE + SULFASAL… Recruiting
  2024-516704-41-00 Phase III/IV 1 country Les Hopitaux Universitaires De Strasbourg
• Comparing the effectiveness of our tailor-made management approach with routine care from a clinical, patient's as well as an economic point… Ended
  2024-511530-12-01 Phase IV 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
• New Clinical End-points in patients with primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients Ended
  2023-510054-16-00 Phase II 7 countries Assistance Publique Hopitaux De Paris
• A Phase 2a Multicenter, Randomized, Double Blind, Parallel, Proof of concept Study Evaluating the Efficacy and Safety of Nipocalimab and Cer… Ended
  2023-504045-31-00 Phase II 3 countries Janssen - Cilag International
• TRIAL EVALUATING EFFICACY AND SAFETY OF HYDROXYCHLOROQUINE VERSUS PLACEBO IN EARLY SYSTEMIC SCLEROSIS (SSc) Ended
  2024-516050-22-00 Phase III 1 country Azienda Ospedaliero-Universitaria Policlinico Umberto I
• PaTcH Trial: A phase 2 study to explore primary and emerging resistance mechanisms in patients with metastatic refractory Pancreatic cancer … Ended
  2024-513429-21-00 Phase II 1 country Cancer Trials Ireland
• RepurpSS-II study Ended
  2024-510904-36-00 Phase II 1 country Universitair Medisch Centrum Utrecht
• Role of Hydroxychloroquine in therapeutic strategy of Head and Neck cancer and Nonsmall cell lung cancer Ended
  2024-516189-12-00 Phase II 1 country Ospedale San Raffaele S.r.l.

Showing 1–20 of 20 trials